Outlook Therapeutics stock jumps ahead of FDA's Dec. 31 Lytenava decision

Retrieve Studio Asset

High Res (1920p) Standard (1280p) Web Friendly (800p)

Note: Asset opens in a secure tab. Right-click → "Save Image As" to download.

This promotional media asset is provided by Barre3 Wellness for the collection Outlook Therapeutics. Authorized for editorial and studio promotional use only.

← Return to Collection